Iniciar sesión Regístrese gratis

Alkermes plc Ingresos Y/Y

¿Qué es el Ingresos Y/Y de Alkermes plc?

El Ingresos Y/Y de Alkermes plc es 3.14%

¿Cuál es la definición de Ingresos Y/Y?

El crecimiento anual de los ingresos de los últimos 3 años es el crecimiento de los ingresos de un año a otro promediado en los últimos 3 años.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Ingresos Y/Y de compañías en Sector Health Care en NASDAQ en comparadas con Alkermes plc

¿Qué hace Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

Empresas con ingresos y/y similar a Alkermes plc